These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 17050117

  • 21. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat.
    Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J, Gonzalez-Cadavid NF.
    Biol Reprod; 2007 May; 76(5):915-23. PubMed ID: 17287493
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Rationale for androgens and erectile dysfunction in 2006.
    Roumeguère T.
    Eur Urol; 2006 Nov; 50(5):898-900. PubMed ID: 16893603
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury.
    Giuliano F, Rubio-Aurioles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE, Pommerville PJ, Colopy MW, Wachs BH, Vardenafil Study Group.
    Spine (Phila Pa 1976); 2008 Apr 01; 33(7):709-15. PubMed ID: 18379396
    [Abstract] [Full Text] [Related]

  • 36. The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy.
    Mehrotra N, Gupta M, Kovar A, Meibohm B.
    Int J Impot Res; 2007 Apr 01; 19(3):253-64. PubMed ID: 16988721
    [Abstract] [Full Text] [Related]

  • 37. The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems.
    Schwarz ER, Kapur V, Rodriguez J, Rastogi S, Rosanio S.
    Int J Impot Res; 2007 Apr 01; 19(2):139-48. PubMed ID: 16761012
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [7 years PDE-5 inhibitor for therapy of erection disorders].
    Krankenpfl J; 2005 Apr 01; 43(7-10):267. PubMed ID: 16518894
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.